Tag: Revelstoke Capital Partners
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks
April 18, 2025HME News Staff
DENVER – Revelstoke Capital Partners, a health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider of chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled infusion...
Revelstoke recaps AOM Infusion
April 15, 2025HME News Staff
DENVER – Revelstoke Capital Partners, a growth-oriented health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider focused on chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled...